A number of studies have shown that NNMT expression is increased as a survival response to disease pathogenesis in diverse diseases including inflammation, cirrhosis, hepatitis, thrombosis and chronic obstructive pulmonary disease [48–52]. The gene discussed is NNMT; the disease is hepatitis A virus infection.